1.Pelvic Inflammatory Disease and Infertility in Female.
Journal of the Korean Medical Association 1999;42(9):868-874
No abstract available.
Female
;
Female*
;
Humans
;
Infertility*
;
Pelvic Inflammatory Disease*
2.Acute Low Abdominal Pain.
Journal of the Korean Medical Association 1997;40(10):1357-1361
No abstract available.
Abdominal Pain*
3.Female Sterilization and Therapeutic Abortion.
Journal of the Korean Medical Association 1997;40(11):1491-1497
No abstract available.
Abortion, Therapeutic*
;
Female*
;
Humans
;
Pregnancy
;
Sterilization, Reproductive*
4.Evaluation of natural cycle IVF & ET.
Korean Journal of Obstetrics and Gynecology 1993;36(8):3297-3306
No abstract available.
5.Comparisons of the outcomes between nonstimulated cycles and clomiphene stimulated cycles in IVF & ET.
Seong Ho YIM ; Hyuck Chan KWON
Korean Journal of Obstetrics and Gynecology 1993;36(4):521-533
No abstract available.
Clomiphene*
6.Comparisons of the outcomes between nonstimulated cycles and clomiphene stimulated cycles in IVF & ET.
Seong Ho YIM ; Hyuck Chan KWON
Korean Journal of Obstetrics and Gynecology 1993;36(4):521-533
No abstract available.
Clomiphene*
7.Degenerative Joint Disease of the Knee
The Journal of the Korean Orthopaedic Association 1971;6(4):365-369
The authores did clinical analysis of 150 cases of the Degenerative Joint Disease of the Knee and reviewed literature.
Joint Diseases
;
Joints
;
Knee
8.5-Fluorouracil, Leucovorin ( FL ) Combination Chemotherapy in Advanced or Recurrent Colo - rectal Cancer.
Jeong Hwan CHO ; Hyuk Chan KWON ; Hyo Jin KIM
Journal of the Korean Cancer Association 1999;31(5):1003-1010
PURPOSE: We studied the effectiveness and toxicities of 5-fluorouracil+leucovorin, combination chemotherapy in advanced or recurred colo-rectal cancer patients, who didn't have previous chemotherapy and enrolled from August 1993 to July 1998. MATERIALS AND METHODS: All patients were treated with leucovorin followed by 5-fluorouracil for 5 consecutive days every 4 weeks. Among 43 patients who were enrolled, 40 patients received treatment at least 2 courses, and they were evaluable. Male to female ratio was 21 to 19. In serum CEA level, 27 patients were greater than 5 ng/ml and 13 were less than 5 ng/ml. And primary site was colon in 21 patients and rectum in 19 patients. RESULTS: The complete response rate was 7,5% and the partial response rate was 25%. The median survival duration was 14.7 months, the median response duration was 16.0 months, and median time to progression was 7.3 months. In the analysis of response, survival duration, time to progression according to various characteristics of patients, serum CEA level and liver involvement were revealed significant difference in survival duration, time to progression (p=0.0122, 00350 & 0.0202, 0.0123) on univariate analysis, but no significant difference on multivariates. Hematologic and non-hematologic toxicities were mild and tolerable. CONCLUSION: This study indicates that the combination of 5-fluorouracil (370 mg/m) and leucovorin (20 mg/m) is effective and tolerable regimen in advanced or recurred colo-rectal cancer patients without previous chemotherapy.
Colon
;
Drug Therapy
;
Drug Therapy, Combination*
;
Female
;
Fluorouracil*
;
Humans
;
Leucovorin*
;
Liver
;
Male
;
Rectal Neoplasms*
;
Rectum
10.Weightlessness-simulated Experimental Apparatus: Hindlimb Unloading Model in Rat-Technical Aspects.
Sang Ho HWANG ; Chan Kwon JUNG
Korean Journal of Aerospace and Environmental Medicine 2005;15(2):52-55
No abstract available.
Animals
;
Hindlimb Suspension*
;
Hindlimb*
Result Analysis
Print
Save
E-mail